IDALOPIRDINE, A 5-HT6 ANTAGONIST IN PHASE III DEVELOPMENT AS ADJUNCTIVE THERAPY TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER’S DISEASE: BASELINE DATA FROM THE ONGOING STARSHINE STUDY

IDALOPIRDINE, A 5-HT6 ANTAGONIST IN PHASE III DEVELOPMENT AS ADJUNCTIVE THERAPY TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER’S DISEASE: BASELINE DATA FROM THE ONGOING STARSHINE STUDY

Saved in:
Bibliographic Details
Published in:Alzheimer's & dementia Vol. 12; no. 7; p. P423
Main Authors: Atri, Alireza, Boneva, Neli, Cummings, Jeffrey L, Frölich, Lutz, Tariot, Pierre N, Windfeld, Kristian
Format: Journal Article
Language:English
Published: Elsevier Inc 01-07-2016
Subjects:
Neurology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2016.06.803